Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therapies into healthcare systems. In this interview, he reflects on the policy landscape, regulatory challenges, and the future of access to these emerging treatments in the EU.

Jeremy Rudy, founder of the Sabba Collective, explains how psychedelic therapy can be integrated into society safely and responsibly — from education to policy.

We spoke with Pavel Bém, a Czech psychiatrist and former mayor of Prague in Vienna during the 69th session of the Commission on Narcotic Drugs (CND) about the country’s latest reforms—from cannabis regulation to psychedelic therapy—and what they mean for the future of drug policy in Europe.

Senator Jeff Steinborn is the sponsor of the Medical Psilocybin Act in New Mexico, a visionary step toward expanding access to psychedelic therapy. In this conversation, filmed at the Psychedelic Science 2025 conference in Denver, he discusses why legislative action was necessary, how to ensure inclusion for marginalized communities, and what benchmarks will define success as New Mexico opens its first healing centers.

Charlotte James is a medicine woman, educator, and founder of the Psychedelic Liberation training. With Afro-Caribbean and Germanic ancestry, her work weaves together ancestral healing, social justice, embodiment, and plant medicine. In our conversation, she speaks about liberation, informed care, the power of ritual, and how to bring accountability and integrity into psychedelic spaces.

Leor Roseman is a psychedelic researcher whose work explores both the individual and collective dimensions of psychedelic experience — from DMT interruption studies to intergroup healing in the Israeli-Palestinian context. In this interview, we discuss how psychedelics may open space not only for personal transformation, but also for collective reconciliation.

Psychedelic therapy can offer spiritual validation and gender euphoria for trans and non-binary people — Jae Sevelius explains what truly affirming psychedelic care means in practice.

Colorado is the second U.S. state to legalize the therapeutic use of psilocybin mushrooms. During the Psychedelic Science conference in June 2025, Drugreporter visited ETC Hospitality in Golden, Colorado — a newly licensed natural medicine healing center — to see how psilocybin-assisted psychotherapy will be practiced in real-world settings.

Clinical psychologist Brian Richards, Psy.D., explains how psychedelics can transform palliative care—from creating truly healing therapeutic spaces to supporting patients facing the end of life.

Two spiritual leaders from different faiths reveal how psychedelics are transforming their understanding of religion, community, and each other — watch Drugreporter’s new interview!